IMMUNOCELLULAR THERAPEUTICS LTD Common Stock
Why Robinhood?
You can watch IMUC and buy or sell other stocks, ETFs, and their options commission-free!About IMUC
ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which engages in the development of immune-based therapies for the treatment of cancers. The company's lead product candidate, ICT-107, is a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells.
IMUC Key Statistics
Stock Snapshot
With a market cap of 1.3M, IMMUNOCELLULAR THERAPEUTICS LTD Common Stock(IMUC) trades at $0.47.
On 2026-05-24, IMMUNOCELLULAR THERAPEUTICS LTD Common Stock(IMUC) stock opened at —, reached a high of —, and a low of —.
The IMMUNOCELLULAR THERAPEUTICS LTD Common Stock(IMUC)'s current trading volume is 0, compared to an average daily volume of 5.57K.
During the past year, IMMUNOCELLULAR THERAPEUTICS LTD Common Stock(IMUC) stock moved between $0.16 at its lowest and $3.20 at its peak.
During the past year, IMMUNOCELLULAR THERAPEUTICS LTD Common Stock(IMUC) stock moved between $0.16 at its lowest and $3.20 at its peak.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.